Vaping Taking Chunks Out Of Big Pharma Profits
With the rise in popularity of vaping, Big Pharma has noticed a drop in their sales of smoking cessation. That means a loss of millions in profits.
.E-cigarettes have experienced a massive boom in popularity in the past few years. Five years ago, only 2.5 million people in the United States used them. They were primarily sold as a smoking cessation aid that looked like a plastic cigarette and only came in a tobacco and menthol flavors. However, with the popularity of flavored liquids and the advancement of electronic cigarette technology, the amount of people who now vape has increased to over 9 million people within the United States.
The Reason is Vaping Works
One of the biggest reasons that e-cigarettes are so popular is because of the high success rate it has in getting smokers tobacco free.
As more and more people become aware of the health dangers of traditional cigarettes, they are switching over to vaping because they actually work. A study that surveyed over 2,000 smokers who were trying to quit found that 92 percent of the subjects smoked less when using e-cigarettes. 96 percent of the survey subjects also said that they were able to stop smoking tobacco cigarettes because of e-cigarettes, and only 10 percent of subjects craved cigarettes anymore. In contrast, people who used nicotine replacement therapy involving patches or gum to stop smoking had a relapse rate of around 33 percent.
Nicorette Sales Drop
However, in the past few decades, pharmaceutical companies have made massive profits from selling smoking cessation aids. Each year, the global market is at about $1.7 billion. Now that e-cigarette sales are so high, Big Pharma is starting to feel threatened. Instead of being a medicinal aid only sold in a few stores, e-cigarettes are now manufactured and sold by specialized e-cigarette companies outside of the pharmacological industry’s control. According to Mintel, the company that produces popular brand Nicorette, they have noticed a 4% decline in their market over the past few years, and this results in millions of dollars of profit being lost.
Pharmaceutical Companies Fighting Dirty
Pharmaceutical companies are trying to fight back and regain their profits by changing the public perception of vaping with skewed research studies. Many studies are trying to show that vaping is supposedly just as dangerous as cigarettes. For example, a 2016 study published in the Journal of Oral Oncology supposedly proved that e-cigarette vapor increased cell death at a rate comparable to cigarette smoke. However, cells were exposed to eight weeks of high-nicotine vapor or just 24 hours of cigarette smoke, so this study actually provides no evidence that vaping is just as dangerous as smoking. Real evidence and detailed health reports that have shown e-cigarettes are 95 percent less dangerous than smoking are often ignored.
Major pharmaceutical companies are also behind many public health campaigns attempting to change the legislation surrounding e-cigarettes. Constant suggestions that flavored e-cigarettes are an attempt to lure children into a dangerous lifestyle are used to push for laws that would greatly restrict the sale of flavored e-juices. Other legislation that would not allow vaping on public property is also being promoted because it would halt vaping while still allowing nicotine patches and gum. By promoting laws that put small vaping stores and manufacturers out of business, the pharmaceutical industry is attempting to stop the growing vaping industry from taking away the profits they get from promoting ineffective smoking cessation aids.
The Global Research Neglect of Unassisted Smoking Cessation: Causes and Consequences
10 Facts That Everyone Gets Wrong About Vaping
Smoking Cessation Market Choked Vaping Sales Surge
Chew on This. Smokers Nicotine Replacement Therapies Rarely Work
Electronic Cigarette Numbers and Percentages